COVID-19 Impact on Global Peripheral Intervention Drug-Eluting Devices Market Insights, Forecast to 2026

1 Study Coverage

• 1.1 Peripheral Intervention Drug-Eluting Devices Product Introduction
• 1.2 Key Market Segments in This Study
• 1.3 Key Manufacturers Covered: Ranking of Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue in 2019
• 1.4 Market by Type
  • 1.4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type
  • 1.4.2 Plain Old Balloon Angioplasty (POBA)
  • 1.4.3 Percutaneous Transluminal Angioplasty (PTA)
• 1.5 Market by Application
  • 1.5.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application
  • 1.5.2 Drug-Eluting Balloons
  • 1.5.3 Drug-Eluting Stents
• 1.6 Coronavirus Disease 2019 (Covid-19): Peripheral Intervention Drug-Eluting Devices Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Peripheral Intervention Drug-Eluting Devices Industry
    • 1.6.1.1 Peripheral Intervention Drug-Eluting Devices Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Peripheral Intervention Drug-Eluting Devices Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Peripheral Intervention Drug-Eluting Devices Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Executive Summary

• 2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Estimates and Forecasts
  • 2.1.1 Global Peripheral Intervention Drug-Eluting Devices Revenue Estimates and Forecasts 2015-2026
  • 2.1.2 Global Peripheral Intervention Drug-Eluting Devices Production Capacity Estimates and Forecasts 2015-2026
  • 2.1.3 Global Peripheral Intervention Drug-Eluting Devices Production Estimates and Forecasts 2015-2026
• 2.2 Global Peripheral Intervention Drug-Eluting Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
• 2.3 Analysis of Competitive Landscape
  • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 2.3.2 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.3.3 Global Peripheral Intervention Drug-Eluting Devices Manufacturers Geographical Distribution
• 2.4 Key Trends for Peripheral Intervention Drug-Eluting Devices Markets & Products
• 2.5 Primary Interviews with Key Peripheral Intervention Drug-Eluting Devices Players (Opinion Leaders)

3 Market Size by Manufacturers

• 3.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production Capacity
  • 3.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production Capacity (2015-2020)
  • 3.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production (2015-2020)
  • 3.1.3 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Production
• 3.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue
  • 3.2.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue (2015-2020)
  • 3.2.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Revenue (2015-2020)
  • 3.2.3 Global Top 10 and Top 5 Companies by Peripheral Intervention Drug-Eluting Devices Revenue in 2019
• 3.3 Global Peripheral Intervention Drug-Eluting Devices Price by Manufacturers
• 3.4 Mergers & Acquisitions, Expansion Plans

4 Peripheral Intervention Drug-Eluting Devices Production by Regions

• 4.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Facts & Figures by Regions
  • 4.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Production (2015-2020)
  • 4.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Revenue (2015-2020)
• 4.2 North America
  • 4.2.1 North America Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
  • 4.2.2 North America Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
  • 4.2.3 Key Players in North America
  • 4.2.4 North America Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
• 4.3 Europe
  • 4.3.1 Europe Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
  • 4.3.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
  • 4.3.3 Key Players in Europe
  • 4.3.4 Europe Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
• 4.4 China
  • 4.4.1 China Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
  • 4.4.2 China Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
  • 4.4.3 Key Players in China
  • 4.4.4 China Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
• 4.5 Japan
  • 4.5.1 Japan Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
  • 4.5.2 Japan Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
  • 4.5.3 Key Players in Japan
  • 4.5.4 Japan Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)

5 Peripheral Intervention Drug-Eluting Devices Consumption by Region

• 5.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Consumption
  • 5.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Consumption (2015-2020)
  • 5.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions Market Share by Consumption (2015-2020)
• 5.2 North America
  • 5.2.1 North America Peripheral Intervention Drug-Eluting Devices Consumption by Application
  • 5.2.2 North America Peripheral Intervention Drug-Eluting Devices Consumption by Countries
  • 5.2.3 U.S.
  • 5.2.4 Canada
• 5.3 Europe
  • 5.3.1 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Application
  • 5.3.2 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Countries
  • 5.3.3 Germany
  • 5.3.4 France
  • 5.3.5 U.K.
  • 5.3.6 Italy
  • 5.3.7 Russia
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Application
  • 5.4.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Regions
  • 5.4.3 China
  • 5.4.4 Japan
  • 5.4.5 South Korea
  • 5.4.6 India
  • 5.4.7 Australia
  • 5.4.8 Taiwan
  • 5.4.9 Indonesia
  • 5.4.10 Thailand
  • 5.4.11 Malaysia
  • 5.4.12 Philippines
  • 5.4.13 Vietnam
• 5.5 Central & South America
  • 5.5.1 Central & South America Peripheral Intervention Drug-Eluting Devices Consumption by Application
  • 5.5.2 Central & South America Peripheral Intervention Drug-Eluting Devices Consumption by Country
  • 5.5.3 Mexico
  • 5.5.3 Brazil
  • 5.5.3 Argentina
• 5.6 Middle East and Africa
  • 5.6.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Application
  • 5.6.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Countries
  • 5.6.3 Turkey
  • 5.6.4 Saudi Arabia
  • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

• 6.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type (2015-2020)
  • 6.1.1 Global Peripheral Intervention Drug-Eluting Devices Production by Type (2015-2020)
  • 6.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2015-2020)
  • 6.1.3 Peripheral Intervention Drug-Eluting Devices Price by Type (2015-2020)
• 6.2 Global Peripheral Intervention Drug-Eluting Devices Market Forecast by Type (2021-2026)
  • 6.2.1 Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Type (2021-2026)
  • 6.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026)
  • 6.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2021-2026)
• 6.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

• 7.2.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Historic Breakdown by Application (2015-2020)
• 7.2.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

• 8.1 Medtronic plc
  • 8.1.1 Medtronic plc Corporation Information
  • 8.1.2 Medtronic plc Overview and Its Total Revenue
  • 8.1.3 Medtronic plc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.1.4 Medtronic plc Product Description
  • 8.1.5 Medtronic plc Recent Development
• 8.2 Boston Scientific Corporation
  • 8.2.1 Boston Scientific Corporation Corporation Information
  • 8.2.2 Boston Scientific Corporation Overview and Its Total Revenue
  • 8.2.3 Boston Scientific Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.2.4 Boston Scientific Corporation Product Description
  • 8.2.5 Boston Scientific Corporation Recent Development
• 8.3 Abbott Laboratories
  • 8.3.1 Abbott Laboratories Corporation Information
  • 8.3.2 Abbott Laboratories Overview and Its Total Revenue
  • 8.3.3 Abbott Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.3.4 Abbott Laboratories Product Description
  • 8.3.5 Abbott Laboratories Recent Development
• 8.4 Cardinal Health
  • 8.4.1 Cardinal Health Corporation Information
  • 8.4.2 Cardinal Health Overview and Its Total Revenue
  • 8.4.3 Cardinal Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.4.4 Cardinal Health Product Description
  • 8.4.5 Cardinal Health Recent Development
• 8.5 B. Braun Melsungen AG
  • 8.5.1 B. Braun Melsungen AG Corporation Information
  • 8.5.2 B. Braun Melsungen AG Overview and Its Total Revenue
  • 8.5.3 B. Braun Melsungen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.5.4 B. Braun Melsungen AG Product Description
  • 8.5.5 B. Braun Melsungen AG Recent Development
• 8.6 Biosensors International Group Ltd.
  • 8.6.1 Biosensors International Group Ltd. Corporation Information
  • 8.6.2 Biosensors International Group Ltd. Overview and Its Total Revenue
  • 8.6.3 Biosensors International Group Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.6.4 Biosensors International Group Ltd. Product Description
  • 8.6.5 Biosensors International Group Ltd. Recent Development
• 8.7 C.R. Bard, Inc.
  • 8.7.1 C.R. Bard, Inc. Corporation Information
  • 8.7.2 C.R. Bard, Inc. Overview and Its Total Revenue
  • 8.7.3 C.R. Bard, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.7.4 C.R. Bard, Inc. Product Description
  • 8.7.5 C.R. Bard, Inc. Recent Development
• 8.8 Abbott
  • 8.8.1 Abbott Corporation Information
  • 8.8.2 Abbott Overview and Its Total Revenue
  • 8.8.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.8.4 Abbott Product Description
  • 8.8.5 Abbott Recent Development
• 8.9 The Lubrizol Corporation
  • 8.9.1 The Lubrizol Corporation Corporation Information
  • 8.9.2 The Lubrizol Corporation Overview and Its Total Revenue
  • 8.9.3 The Lubrizol Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.9.4 The Lubrizol Corporation Product Description
  • 8.9.5 The Lubrizol Corporation Recent Development
• 8.10 Terumo Corporation
  • 8.10.1 Terumo Corporation Corporation Information
  • 8.10.2 Terumo Corporation Overview and Its Total Revenue
  • 8.10.3 Terumo Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.10.4 Terumo Corporation Product Description
  • 8.10.5 Terumo Corporation Recent Development

9 Production Forecasts by Regions

• 9.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions Forecast by Revenue (2021-2026)
• 9.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions Forecast by Production (2021-2026)
• 9.3 Key Peripheral Intervention Drug-Eluting Devices Production Regions Forecast
  • 9.3.1 North America
  • 9.3.2 Europe
  • 9.3.3 China
  • 9.3.4 Japan

10 Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region

• 10.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
• 10.2 North America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
• 10.3 Europe Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
• 10.4 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
• 10.5 Latin America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
• 10.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
  • 11.2.2 Peripheral Intervention Drug-Eluting Devices Distributors
• 11.3 Peripheral Intervention Drug-Eluting Devices Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

• 12.1 Market Opportunities and Drivers
• 12.2 Market Challenges
• 12.3 Market Risks/Restraints
• 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Peripheral Intervention Drug-Eluting Devices Study

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details